These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 2033960

  • 1. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
    Grant S, Pettit GR, Howe C, McCrady C.
    Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
    [Abstract] [Full Text] [Related]

  • 2. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S, Pettit GR, McCrady C.
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [Abstract] [Full Text] [Related]

  • 3. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR.
    Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908
    [Abstract] [Full Text] [Related]

  • 4. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 5. Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF.
    McCrady CW, Staniswalis J, Pettit GR, Howe C, Grant S.
    Br J Haematol; 1991 Jan; 77(1):5-15. PubMed ID: 1998597
    [Abstract] [Full Text] [Related]

  • 6. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD.
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [Abstract] [Full Text] [Related]

  • 7. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH, Talpaz M, Deisseroth AB, Estrov Z.
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C, Mangoni L, Almici C, Frassoni F, Fiers W, Rizzoli V.
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [Abstract] [Full Text] [Related]

  • 11. Modulation by bryostatin 1 of the in vitro radioprotective effects of the GM-CSF/IL-3 fusion protein, PIXY 321, on normal human myeloid progenitors.
    Grant S, Traylor R, Pettit GR, Lin PS.
    Cytokine; 1993 Sep; 5(5):490-7. PubMed ID: 8142605
    [Abstract] [Full Text] [Related]

  • 12. Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts.
    Grant S, Jarvis WD, Turner AJ, Wallace HJ, Pettit GR.
    Br J Haematol; 1992 Nov; 82(3):522-8. PubMed ID: 1486032
    [Abstract] [Full Text] [Related]

  • 13. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
    Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Graham G.
    Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363
    [Abstract] [Full Text] [Related]

  • 14. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 15. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
    Asano Y, Shibuya T, Okamura S, Yamaga S, Otsuka T, Niho Y.
    Cancer Res; 1987 Nov 01; 47(21):5647-8. PubMed ID: 3499216
    [Abstract] [Full Text] [Related]

  • 16. Modest stimulatory effect of recombinant human GM-CSF on colony growth from peripheral blood human megakaryocyte progenitor cells.
    Mazur EM, Cohen JL, Wong GG, Clark SC.
    Exp Hematol; 1987 Dec 01; 15(11):1128-33. PubMed ID: 3315723
    [Abstract] [Full Text] [Related]

  • 17. The differentiation inducing effect of bryostatin 5 on human myeloid blast cells is potentiated by vitamin D3.
    van der Hem KG, Dräger AM, Huijgens PC, Tol C, Devillé W, Langenhuijsen MM.
    Leukemia; 1994 Feb 01; 8(2):266-73. PubMed ID: 7508534
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec 01; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 19. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 01; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 20. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD, Stackpoole A, Meager A, Tikerpae J.
    J Immunol; 1992 Oct 15; 149(8):2681-8. PubMed ID: 1383322
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.